Novartis has reportedly filed a lawsuit against Takeda in the United States. The fear is that trade secrets have been passed on by a former employee.
According to a media report, Novartis has filed a lawsuit in the United States against its Japanese competitor Takeda Pharmaceuticals. The Swiss drugmaker wanted to determine whether a former Novartis employee had illegally transferred trade secrets, the Nikkei newspaper wrote in an online article published on Friday evening (Swiss time).
Novartis asked the Massachusetts Supreme Court to issue a subpoena to examine Takeda’s documents and business records. The article continued that Takeda confirmed legal steps at Nikkei’s request. “We have informed Novartis on multiple occasions that Takeda is actively investigating the matter,” a Takeda spokesperson was quoted as saying.
A Novartis spokesperson told Nikkei that the company “takes the confidentiality and security of our proprietary information very seriously and will take steps to protect this information from inappropriate disclosure or use.”
According to the complaint, the former Novartis employee transferred about 10,000 internal files to his personal email address a month before leaving the company in May. The documents included sales, technical and financial data, according to the complaint submitted to the court. The employee then transferred to Takeda in July, Novartis said in the complaint.
It appears that the Basel-based pharmaceutical giant now wants to know whether trade secrets were passed on and whether Takeda used the information.